AGIL Q2 results OK; to sell 25% stake in AGL Proteins, fund Thailand arm

Results restatedEmphasis of matterRelated-party transactionsProfit growth above 25%Results View source PDF Explain this filing

ASIANTILES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹66.60

prior close

₹68.19

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%+1.9% vs market

Ceramics peers, median of 10sector-0.3%+3.2% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 3.2 pts more than its Ceramics peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9+0.9+1.9-0.3+3.2

Next day

-0.4+0.8-1.2-0.7+0.4

+0.6+0.7-0.1-0.5+1.1

+3.1+1.3+1.7-1.3+4.4

+2.1+0.5+1.6-1.7+3.8

+0.6+0.4+0.2-1.9+2.5

-1.9-1.5-0.4-4.2+2.3

15d

-3.9-2.4-1.4-8.9+5.0

-3.9-4.4+0.5-7.0+3.1

+6.7-7.2+13.9-12.2+18.9

+6.6-5.0+11.6-11.5+18.2

UpDownMarket · Nifty Microcap 250Sector · Ceramics peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 results. Standalone revenue Rs 272.42 cr, PAT Rs 7.79 cr vs Rs 1.31 cr YoY. Consolidated revenue Rs 406.92 cr, PAT Rs 16.71 cr vs Rs 1.25 cr. Approved sale of 25% stake in subsidiary AGL Proteins for Rs 25,000 (unit not yet operational). Capital to be raised in Thailand WOS for working capital. Results include retrospective effect of NCLT-approved scheme effective Oct 2023.

Likely market impact

Reported PAT growth strong but YoY distorted by scheme restatement. Subsidiary sale is minor; Thailand infusion modest.